Reacción #1328451

ord-9090868186c347a2ae92318aa98b115e

Ecuación de reacción

Cn1c(C(F)(F)F)cc(=O)n(-c2cc(Oc3ccccc3O)c(Cl)cc2F)c1=O
2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenol
O=C([O-])[O-].[K+].[K+]
potassium carbonate
[Cl-].[Na+]
sodium chloride
CC(C)(C)OC(=O)CCl
t-butyl chloroacetate
Cn1c(C(F)(F)F)cc(=O)n(-c2cc(Oc3ccccc3OCC(=O)OC(C)(C)C)c(Cl)cc2F)c1=O
t-butyl [2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenoxy]acetate

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.ADDITIONwas added
  2. 2
    workup.STIRRINGthe mixture was stirred at 40° C. to 60° C. for 2 hours
  3. 3
    workup.WAITAfter left
  4. 4
    Temperaturafor cooling
  5. 5
    Otrothe mixture was subjected to phase separation
  6. 6
    LavadoThe organic layer was washed with saturated aqueous sodium chloride solution
  7. 7
    Secadodried over magnesium sulfate
  8. 8
    Concentraciónconcentrated

Procedimiento

First, 0.20 g of 2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenol was dissolved in 2 ml of N,N-dimethylformamide, to which 0.083 g of potassium carbonate was added, and the mixture was stirred at room temperature for 50 minutes. Then, 0.077 g of t-butyl chloroacetate was added, and the mixture was stirred at 40° C. to 60° C. for 2 hours. After left for cooling, ice water was poured into the reaction mixture, and after addition of ethyl acetate and saturated aqueous sodium chloride solution, the mixture was subjected to phase separation. The organic layer was washed with saturated aqueous sodium chloride solution, dried over magnesium sulfate, and then concentrated. The residue was subjected to silica gel column chromatography (eluent: n-hexane/ethyl acetate=6/1) to give 10.39 g of t-butyl [2-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-1,2,3,6-tetrahydropyrimidin-1-yl]phenoxy}phenoxy]acetate (compound a-121).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07115544B2uspto-grants-2006_10